Friday, January 30, 2026

Is Russia Protecting North Korea’s Illegal Acts?

The Ministry of Unification expressed deep regret...

South Korea’s North Korean Human Rights Policy Needs Bipartisan Consistency

A visit to Iran reshaped perceptions, highlighting shared humanity and the complexities of North Korean human rights discussions in South Korea.

Yoon and Japan’s New PM Ishiba to Hold Summit Amid ASEAN Meeting

South Korean President Yoon Suk Yeol will meet Japanese Prime Minister Shigeru Ishiba on Thursday to discuss bilateral relations.

Tag: Samsung Biologics

Samsung Biologics Earns EcoVadis Platinum: What Joining the Top 1% Signals for Global Pharma Supply Chains

Samsung Biologics achieves Platinum rating from EcoVadis, recognizing its top-tier ESG performance in sustainability and corporate responsibility.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Global Pharma Giants Join Samsung Biologics in Major Climate Pledge to Cut Supply-Chain Emissions by 2030

Samsung Biologics leads a global initiative to reduce carbon emissions in healthcare, aiming for sustainability and renewable energy by 2030.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Samsung Biologics Targets Japan’s $12.3 Billion CDMO Market: What You Need to Know

Samsung Biologics expands in Japan, targeting top pharma firms with new CMO brand 'ExellenS' and enhancing production capabilities.

Samsung Launches New Mini-Organ Tech to Speed Up Cancer Drug Testing

Samsung Biologics launches Samsung Organoids for drug screening, focusing on anticancer candidates to enhance precision and reduce costs.

Top News

- Our Sponsors Ad -

Follow us